First-in-human study of [68Ga]Ga-AAZTA-093, a novel PSMA-targeting agent, in patients with prostate cancer

被引:0
|
作者
Wang, G. [1 ]
Jin, W. [2 ]
Luo, Y. [2 ]
Wang, R. [2 ]
Zhu, L. [2 ]
Kung, H. [3 ]
Miao, W. [1 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
[2] Beijing Normal Univ, Beijing, Peoples R China
[3] Univ Penn, Philadelphia, PA USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0281
引用
收藏
页码:S542 / S542
页数:1
相关论文
共 50 条
  • [1] Novel [68Ga/177Lu]Ga/Lu-AAZTA-PSMA-093 as PSMA targeting agent for diagnosis and radiotherapy
    Liu, Tianqing
    Wang, Ran
    Jin, Wenbin
    Luo, Yang
    Hong, Haiyan
    Zhao, Ruiyue
    Li, Linlin
    Yan, Li
    Qiao, Jinping
    Zhu, Lin
    Kung, Hank
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S304 - S305
  • [2] Novel [68Ga/177Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy
    Wang, Ran
    Jin, Wenbin
    Luo, Yang
    Hong, Haiyan
    Zhao, Ruiyue
    Li, Linlin
    Yan, Li
    Qiao, Jinping
    Ploessl, Karl
    Zhu, Lin
    Kung, Hank F.
    MOLECULAR PHARMACEUTICS, 2024, 21 (07) : 3256 - 3267
  • [3] Novel [68Ga/177Lu]Ga/Lu-AZ-093 as PSMA-targeting agent for diagnosis and radiotherapy
    Wang, Ran
    Jin, WenBin
    Luo, Yang
    Hong, Haiyan
    Zhao, Ruiyue
    Li, Linlin
    Yan, Li
    Qiao, Jinping
    Ploessl, Karl
    Zhu, Lin
    Kung, Hank F.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [4] A pilot prospective comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-617 in the same group of prostate cancer patients
    Wang, Guochang
    Zang, Jie
    Hong, Haiyan
    Liu, Qingxing
    Jiang, Yuanyuan
    Zhu, Zhaohui
    Zhu, Lin
    Kung, Hank
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [5] First in human experience with [68Ga]P16-093, a novel Ga-68 labeled Prostate Specific Membrane Antigen (PSMA) inhibitor
    Doot, Robert
    Alexoff, David
    Pryma, Daniel
    Labban, Kyle
    Schubert, Erin
    Fillare, Matthew
    Ploessl, Karl
    Choi, Seok
    Zha, Zhihao
    Mankoff, David
    Kung, Hank
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [6] Initial evaluation of the PS targeted PET agent [68Ga]Ga-P16-093, and comparison with [68Ga]Ga-PSMA-11, in prostate cancer patients presenting with biochemical recurrence.
    Green, Mark
    Hutchins, Gary
    Fletcher, James
    Bahler, Clint
    Tann, Mark
    Sims, Justin
    Mathias, Carla
    Territo, Wendy
    Polson, Heather
    Alexoff, David
    Kung, Hank
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [7] First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients
    Zhao, Ruiyue
    Ke, Miao
    Lv, Jie
    Liu, Shaoyu
    Liu, Yuheng
    Zhang, Jing
    Xu, Lifu
    Gu, Di
    Li, Mingzhao
    Cai, Chao
    Liu, Yongda
    Zeng, Guohua
    Alexoff, David
    Ploessl, Karl
    Zhu, Lin
    Kung, Hank F.
    Wang, Xinlu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (06) : 1753 - 1762
  • [8] First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients
    Ruiyue Zhao
    Miao Ke
    Jie Lv
    Shaoyu Liu
    Yuheng Liu
    Jing Zhang
    Lifu Xu
    Di Gu
    Mingzhao Li
    Chao Cai
    Yongda Liu
    Guohua Zeng
    David Alexoff
    Karl Ploessl
    Lin Zhu
    Hank F. Kung
    Xinlu Wang
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1753 - 1762
  • [9] A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
    Guochang Wang
    Linlin Li
    Ming Zhu
    Jie Zang
    Jiarou Wang
    Rongxi Wang
    Weigang Yan
    Lin Zhu
    Hank F. Kung
    Zhaohui Zhu
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3126 - 3136
  • [10] A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-617 PET/CT in patients with primary prostate cancer
    Wang, G.
    Li, L.
    Yan, W.
    Zhu, L.
    Kung, H.
    Zhu, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S216 - S216